POM-V Prescription Required

VIMCO Emulsion for Injection for Ewes and Female Goats

Active ingredient: Staphylococcus aureus

Form

Injection

Species

Goats Sheep

Manufacturer

Laboratorios Hipra SA

VMD MA No.

17533/3001

What it's used for

For active immunisation of healthy female goats problems, to reduce the incidence of sub-clinical mastitis caused by aureus Coagulase-Negative Staphylococc...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Staphylococcus aureus

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

VIMCO Emulsion for Injection for Ewes and Female Goats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For active immunisation of healthy female goats
problems, to reduce the incidence of sub-clinical mastitis caused by
aureus
Coagulase-Negative Staphylococci* however occurs, the severity of clinical signs
(udder and milk aspect) is reduced.
(*Determination of the CNS species has not been performed)
-
Ewes: 6 weeks
Goats: has not been established (see section 4)
-

Allow the vaccine to reach a temperature of +15 ºC to +25 ºC before administration.
Shake before use.
Minimum age at vaccination: 8 months.
Basic vaccination: Administer one dose (2 ml) by deep intramuscular injection in the
neck muscles at 5 weeks before the expected parturition date and 3 weeks after the
first dose, administer a second dose.
Revaccination: The basic vaccination scheme is to be repeated prior to each lactation.

None.

Ewes and adult female goats:
Very common
(>1 animal / 10 animals
treated):
Injection site swelling
.Common
(1 to 10 animals / 100 animals
treated):
Injection site swelling
, Elevated temperature
.Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Anaphylactic-type reaction
, apathy
, anorexia,
recumbency.
Swelling of less than 2 cm in diameter which disappears within 12 days at most.
Swelling higher than 5 cm in diameter which resolves within 3 days at most.
Transient reaction of up to 1.8ºC occurred between the first 4 hours and 3 days after
injection, which spontaneously resolves within some days without compromising
animal health status.
Reactions might be life-threatening and/or cause abortion. In such cases,
appropriate and rapid symptomatic treatment should be administered.
Mild.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder <or its local representative> or the
national competent authority via the national reporting system. See the package
leaflet for respective contact details.
AN: 03684/2022Page 4 of 6

Vaccinate healthy animals only.
Immunisation has to be considered as one component in a complex mastitis control
programme that addresses all important udder health factors (e.g. milking technique,
dry-off and breeding management, hygiene, nutrition, housing, bedding, animal
comfort, air and water quality, health monitoring) and other management practices.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
To the user:
This veterinary medicinal product contains mineral oil. Accidental injection/self-
injection may result in severe pain and swelling, particularly if injected into a joint or
finger, and in rare cases could result in the loss of the affected finger if prompt
medical attention is not given.
AN: 03684/2022Page 3 of 6
If you are accidentally injected with this veterinary medicinal product, seek prompt
medical advice even if only a very small amount is injected and take the package
leaflet with you. If pain persists for more than 12 hours after medical examination,
seek medical advice again.
To the physician:
This veterinary medicinal product contains mineral oil. Even if small amounts have
been injected, accidental injection with this veterinary medicinal product can cause
intense swelling, which may, for example, result in ischaemic necrosis and even the
loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate
early incision and irrigation of the injected area, especially where there is
involvement of finger pulp or tendon.
Special precautions for the protection of the environment:
Not applicable.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case by
case basis.

Store and transport refrigerated (2 C – 8 C).
Do not freeze.
Protect from light.

Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.